Background/Objectives: Cancer is the second most common cause of death in Poland, responsible for 26.7% of deaths in 2023. Our aim was to estimate total direct and indirect costs of cancer in Poland. Methods: We acquired epidemiological data from the System Analysis and Implementation Database provided Polish Ministry of Health. For estimating the direct costs of medical procedures and chemotherapy, we used statistics of homogeneous groups of patients provided by the Polish National Health Fund. For analyzing the indirect costs in the field of absenteeism we acquired data from Statistical Portal of Polish Social Insurance Institution. Results: The total direct costs of treatment for cancer in the adult population in the period 2021–2023 to be equal to USD 192,935,858, taking purchasing power parity of Polish currency into account. This was equal to 0.00394% of General Domestic Product. The costs associated with absenteeism were equal to USD 3,103,526,321, which was equal to 0.063% of GDP. The sum of Years of Potential Life Lost was equal to 930,962 and the sum of Years of Potential Productive Life Lost was equal to 363,511. Cancer morbidity and incidence in the period 2021–2023 increased by 1.3%. Mortality increased by 2.1%. The total cost of medical services relative to GDP in 2022 was lower than in 2021; in 2023, however, it was higher than both in 2021 and 2022. The cost of chemotherapy, both in absolute numbers and relative to GDP, was significantly lower in 2022 than in 2021. Conclusions: In 2023, the cost was higher than in 2021 and in 2022. The costs of absenteeism in three consecutive years increased. Years of Potential Life Lost and Years of Potential Productive Life Lost due to cancer increased substantially in the period 2021–2023, both for males and for females, in all three age groups.
背景/目的：癌症是波兰第二大常见死因，2023年占死亡总数的26.7%。本研究旨在估算波兰癌症相关的总直接与间接成本。方法：流行病学数据来源于波兰卫生部系统分析与实施数据库。医疗程序及化疗直接成本估算采用波兰国家健康基金提供的患者同质分组统计数据。缺勤相关间接成本分析数据来自波兰社会保险机构统计门户。结果：经购买力平价调整后，2021-2023年波兰成年人口癌症治疗总直接成本为192,935,858美元，相当于国内生产总值的0.00394%。缺勤相关成本达3,103,526,321美元，占GDP的0.063%。潜在寿命损失年总数达930,962年，潜在生产寿命损失年总数达363,511年。2021-2023年间癌症患病率与发病率增长1.3%，死亡率上升2.1%。2022年医疗服务总成本占GDP比重较2021年下降，但2023年该比重反超前两年。2022年化疗成本（包括绝对数值及GDP占比）显著低于2021年。结论：2023年癌症治疗成本高于2021年及2022年。连续三年缺勤成本持续增长。2021-2023年间，所有三个年龄组中男女两性因癌症导致的潜在寿命损失年与潜在生产寿命损失年均显著增加。
Direct and Indirect Costs of Cancer in Adult Population of Poland in the Period 2021–2023
肿瘤(癌症)患者之家